Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC
- PMID: 38351345
- DOI: 10.1038/s41388-024-02960-2
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC
Abstract
Metastasis causes most cancer-related deaths, and the role and mechanism of periostin (POSTN) in the metastasis of hepatocellular carcinoma (HCC) remain undiscovered. In this study, DEN and HTVi HCC models were performed in hepatic-specific Postn ablation and Postn knock-in mouse to reveal the role of POSTN in HCC metastasis. Furthermore, POSTN was positively correlated with circulating EPCs level and promoted EPC mobilization and tumour infiltration. POSTN also mediated the crosstalk between HCC and EPCs, which promoted metastasis ability and upregulated CD36 expression in HCC through indirect crosstalk. Chemokine arrays further revealed that hepatic-derived POSTN induced elevated CCL2 expression and secretion in EPCs, and CCL2 promoted prometastatic traits in HCC. Mechanistic studies showed that POSTN upregulated CCL2 expression in EPCs via the αvβ3/ILK/NF-κB pathway. CCL2 further induced CD36 expression via the CCR2/STAT3 pathway by directly binding to the promoter region of CD36. Finally, CD36 was verified to have a prometastatic role in vitro and to be correlated with POSTN expression, metastasis and recurrence in HCC in clinical samples. Our findings revealed that crosstalk between HCC and EPCs is mediated by periostin/CCL2/CD36 signalling which promotes HCC metastasis and emphasizes a potential therapeutic strategy for preventing HCC metastasis.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Similar articles
-
Bone Marrow Mesenchymal Stromal Cell-Derived Periostin Promotes B-ALL Progression by Modulating CCL2 in Leukemia Cells.Cell Rep. 2019 Feb 5;26(6):1533-1543.e4. doi: 10.1016/j.celrep.2019.01.034. Cell Rep. 2019. PMID: 30726736
-
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.Gut. 2017 Jan;66(1):157-167. doi: 10.1136/gutjnl-2015-310514. Epub 2015 Oct 9. Gut. 2017. PMID: 26452628
-
A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.J Exp Clin Cancer Res. 2021 Jun 30;40(1):218. doi: 10.1186/s13046-021-02011-8. J Exp Clin Cancer Res. 2021. PMID: 34193219 Free PMC article. Clinical Trial.
-
[Effects of periostin on hepatocellular carcinoma cells invasion, metastasis and prognosis].Zhonghua Gan Zang Bing Za Zhi. 2019 Oct 20;27(10):766-771. doi: 10.3760/cma.j.issn.1007-3418.2019.10.006. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31734990 Chinese.
-
Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling.J Biomed Sci. 2022 Dec 22;29(1):109. doi: 10.1186/s12929-022-00888-x. J Biomed Sci. 2022. PMID: 36550569 Free PMC article.
Cited by
-
CCL2 Predicts Survival in Patients with Inoperable Hepatocellular Carcinoma Undergoing Selective Internal Radiotherapy.Cancers (Basel). 2024 Aug 12;16(16):2832. doi: 10.3390/cancers16162832. Cancers (Basel). 2024. PMID: 39199602 Free PMC article.
-
Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways.Front Cell Dev Biol. 2024 Jun 12;12:1399065. doi: 10.3389/fcell.2024.1399065. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38933330 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous